Clinical and Market Analysis of NanoBEO: A Public-Worth, Innovative Therapy for Behavioral and Psychological Symptoms of Dementia (BPSD)—Emerging Evidence and Its Implications for a Health Technology Assessment (HTA) and Decision-Making in National Health Systems

Background: According to scientific literature, some 99% of patients affected by Alzheimer’s disease (AD) suffer from behavioral and psychological symptoms of dementia (BPSD), also known as neuropsychiatric symptoms (NPSs). In particular, agitation is one of the most difficult disorders to treat. St...

Полное описание

Библиографические подробности

Главные авторы:	Damiana Scuteri, Daniele Pierobon, Martina Pagliaro, Kengo Hamamura, Takafumi Hayashi, Loris Pignolo, Pierluigi Nicotera, Giacinto Bagetta, Maria Tiziana Corasaniti
Формат:	Artigo
Язык:	Inglês
Опубликовано:	MDPI AG 2024-09-01
Серии:	Pharmaceutics
Предметы:	NanoBEO HTA clinical and market analysis essential oil of bergamot dementia BPSD
Online-ссылка:	https://www.mdpi.com/1999-4923/16/10/1253
Метки:	Добавить метку Нет меток, Требуется 1-ая метка записи!